A California start-up has the green light to advertise a mail order DNA test that screens for a rare genetic disorder, after a u-turn from the U. S. Food and Drug Administration.
The agency says in general carrier tests will no longer require advance FDA approval before they can be marketed.
Tech Correspondent Rachel Silverman reports.
IN: “The Silicon Valley”
OUT: SOC
DUR: 31 seconds